Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19
7.10.2021
0:00
17:22
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
Weitere Episoden von „Coronavirus (COVID-19) Q&A“
Verpasse keine Episode von “Coronavirus (COVID-19) Q&A” und abonniere ihn in der kostenlosen GetPodcast App.